Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development

NCT03780673 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhoses

Interventions

DRUG: Simvastatin
DRUG: Rifaximin
DRUG: Placebo of Simvastatin
DRUG: Placebo of Rifaximin

Sponsor

Judit Pich